Nusano supplies medical radioisotopes and is involved in radioisotope production. The company aims to meet the increasing need for medical radioisotopes with its advanced technology in the production process.

Nusano

Nusano | 4,139 followers on LinkedIn. Helping fight cancer by bringing supply stability and innovation to medical radioisotopes  | No patient should be denied the cancer care they need simply because some options are in short supply or unavailable. Yet, all too often, this is what happens.

Nusano is a physics company that creates radioisotopes—tiny tracers used by doctors to diagnose and treat cancer and other diseases.

CFO | Exec Committee Member, Business Development, Venture Finance, Portfolio Strategy, FP&A, Investor Relations

Pushkar Bedekar

Jong Yi

Senior Mechanical Engineer

Chris Bailey

People Executive | Start Up Advisor

Maggie Kruse

Nusano is proud to share that our very own Gregory Moffitt is a member of Utah Business ' 2024 Healthcare Heroes! Opening in 2025, Nusano’s West Valley City, Utah production facility will make medical radioisotopes in quantities and varieties unsurpassed by other methods. Radioisotopes are essential components in the active pharmaceutical ingredients (APIs) of drugs detecting illnesses and fighting cancers. Greg and the teams at Nusano are at the forefront of solving supply chain issues threatening the entire #radiopharmaceuticals industry so more patients can access new and emerging cancer therapies. Congrats to Greg, and thank you to Utah Business for this honor. #radioisotopes #supplychain #oncology #cancer

Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development: https://lnkd.in/gnuhxGyg #radiopharmaceuticals #radioisotopes #supplychain #radiotherapeutics #oncology #cancer #isotopes #STR #EANM24

Seat belts fastened. Tray tables in their full upright position. We're ready to take off to #EANM24 . To connect or simply say "hallo" to the Nusano team in Hamburg, email sales(at) nusano.com . #radioisotopes #supplychain #radiotherapeutics #radiopharmaceuticals #oncology #cancer

Nusano presenting at industry events in October: https://lnkd.in/gGv468mZ #Oppenheimer #biofuture #jonesresearch #EANM #radiopharmaceuticals #radioisotopes #supplychain

Nusano welcomes Kevin Haehl & Jzaneen Damji to executive leadership team; announces promotions of Rohan Jain & Christopher Ignace : https://lnkd.in/gyRyHNms

Exciting stuff! So proud to be a part of our Nusano team! 👏🏽

Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes: https://lnkd.in/g8CqDKc8 #radioisotopes #radiopharmaceuticals #isotopes #oncology #lutetium #actinium #Lu177 #Ac225 #supplychain #Utah

In an Insights Care interview, Nusano CEO Chris Lowe discusses the urgent need for new medical radioisotope supplies, how Nusano will be part of the solution, and his advice for young professionals entering the radiopharmaceuticals industry. Read: https://lnkd.in/grN84sMX #radioisotopes #isotopes #radiotherapeutics #careeradvice #cancer #radiopharmaceuticals #supplychain #innovation

Our thanks to BioUtah for featuring Nusano in the new issue of Biosphere Magazine entitled "Profiles in Innovation." Opening in 2025, our West Valley City, UT production facility will help supply the fight against cancer by making medical radioisotopes available and abundant. We look forward to working with drugmakers, researchers and clinicians to support continued innovation in radiotherapeutics. Read more in Biosphere Magazine: https://lnkd.in/g8xzWMVV #cancer #isotopes #radioisotopes #radiotherapeutics #Utah #supplychain #innovation

We're headed to Bethesda, Maryland on September 19-21 for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Fall Therapeutics conference. Stop by our booth or reach out to set up a meeting: sales(at) nusano.com .

Metric
Company Name	Nusano
Symbol
MSH ID	COM:NUSANO
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Pharmaceuticals
Country	US
Stage
Employee Count
Website	nusano.com
LinkedIn	nusano
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

NUSA

COM:NUSANO

Nusano

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue